Cytomegalovirus (CMV) colitis associated with chemotherapy and molecular targeted therapy for gynecologic cancer: A case report of ovarian cancer
-
- Komatsu Nahoko
- Obstetrics and Gynecology, Nagasaki University Hospital
-
- Shimada Takako
- Obstetrics and Gynecology, Nagasaki University Hospital
-
- Higashijima-Nagata Ai
- Obstetrics and Gynecology, Nagasaki University Hospital
-
- Ohashi Kazuaki
- Obstetrics and Gynecology, Nagasaki University Hospital
-
- Abe Syuhei
- Obstetrics and Gynecology, Nagasaki University Hospital
-
- Miura Kiyonori
- Obstetrics and Gynecology, Nagasaki University Hospital
この論文をさがす
抄録
Cytomegalovirus (CMV) colitis associated with chemotherapy for gynecologic cancer is rare. We report a case of CMV colitis linked to treatment with paclitaxel/carboplatin (TC) and bevacizumab (BEV) for ovarian cancer. Our patient was a 59-year-old woman who completed one course of TC chemotherapy and one course of TC + BEV as neoadjuvant chemotherapy for advanced ovarian cancer. On the 7th day of TC + BEV therapy, she visited our hospital for continuous diarrhea, abdominal pain, and melena. Grade 4 neutropenia and fever were also detected. She was diagnosed as CMV colitis via colonoscopy and histopathological examination. This is the first case report of CMV colitis complicated by chemotherapy-induced febrile neutropenia during the treatment for gynecologic cancer.
収録刊行物
-
- Acta Medica Nagasakiensia
-
Acta Medica Nagasakiensia 65 (1), 17-19, 2021
長崎大学医学部
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390852735461261952
-
- NII論文ID
- 130008106743
-
- NII書誌ID
- AA00508430
-
- HANDLE
- 10069/00040790
-
- ISSN
- 00016055
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可